AI-based programmatic marketing platform, Doceree said it raised a $35 million Series B round led by Creaegis, the leading digital and technology investment firm. Existing investors, Eight Roads Ventures, and F-Prime Capital, also participated in the round. 

The company intends to distribute this capital infusion to accelerate product development, augment technologies, scale global expansion, and expand the team, it added. 

In order to improve patient health outcomes, the company provides pharmaceutical, life sciences, and healthcare media agencies with solutions that seamlessly target HCPs on their networks and within their digital workflows. With the support of its programmatic messaging capabilities and the company's largest worldwide network of HCP-only digital platforms, clients around the world can now maximise the performance of their physician engagement programs. 

“We are pioneering HCP messaging solutions that are first to market. It is incredible to watch our innovative products disrupt the space and drive the adoption of programmatic technology in the life-sciences industry, not just in evolved markets like the US, but also elsewhere in the same vein. We have been able to simplify HCP engagement globally with our unique AI-enabled proprietary technology and offer quality end-to-end HCP-targeting solutions that have helped our clients succeed with profitable growth. The pharma messaging space is evolving at a fast pace and our solutions are aligned to meet the immediate requirements of the life sciences industry. The investment speaks volumes about the value we are creating in the space,” said Harshit Jain MD, founder and global CEO of Doceree.   

Since receiving its series A funding in April 2022, Doceree has grown by more than 100 per cent, and it has now introduced market-first innovations on both the demand and supply sides, such as Doceree Enterprise, a global Demand Side Platform (DSP) with an HCP focus, and Doceree Provider, which enables HCPs to improve patient health outcomes. Its HCP marketing ecosystem is made up of specially created technologies that give life science marketers the tools they need to interact with doctors at the right times with contextual messaging and analyze campaign results to increase script lift, the company said in a statement. 

Prakash Parthasarathy, Managing Partner and CIO, and Nitish Bandi, partner of Creaegis, said, “Our past experience of investing in pioneering global SaaS companies and in the healthcare ecosystem will enable us to support the company’s mission to create superior outcomes for pharma brands, providers and patients.” 

Apart from the markets of the US, India, and Europe, the company has expanded its footprints to Africa, Southeast Asia (SEA), and the Gulf Cooperation Council (GCC), curating and iterating solutions that serve the specific needs of marketers in these regions.